Disease overview
Alterations
124 total · Types A (molecular) through E (functional). Molecular rows are Open Targets gene–disease associations (evidence column = OT association score), not measured levels; phenotypes are HPO terms annotated directly to this disease (Monarch); type T rows are outcome measures used in completed ClinicalTrials.gov studies, not alterations of the disease.
| Name | Type | Subtype | Direction | Frequency | Evidence | Sources | Links |
|---|---|---|---|---|---|---|---|
| SLC6A2
solute carrier family 6 member 2 |
Molecular | Gene | — | — | OT score 0.51 | Open Targets | UniProt Ensembl Open Targets |
| HCN4
hyperpolarization activated cyclic nucleotide gated potassium channel 4 |
Molecular | Gene | — | — | OT score 0.29 | Open Targets | UniProt Ensembl Open Targets |
| SLC6A4
solute carrier family 6 member 4 |
Molecular | Gene | — | — | OT score 0.27 | Open Targets | UniProt Ensembl Open Targets |
| NR3C1
nuclear receptor subfamily 3 group C member 1 |
Molecular | Gene | — | — | OT score 0.18 | Open Targets | UniProt Ensembl Open Targets |
| ADRB1
adrenoceptor beta 1 |
Molecular | Gene | — | — | OT score 0.11 | Open Targets | UniProt Ensembl Open Targets |
| ADRB2
adrenoceptor beta 2 |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRB3
adrenoceptor beta 3 |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA1A
adrenoceptor alpha 1A |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA1B
adrenoceptor alpha 1B |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA1D
adrenoceptor alpha 1D |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA2C
adrenoceptor alpha 2C |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA2A
adrenoceptor alpha 2A |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| ADRA2B
adrenoceptor alpha 2B |
Molecular | Gene | — | — | OT score 0.10 | Open Targets | UniProt Ensembl Open Targets |
| AGT
angiotensinogen |
Molecular | Gene | — | — | OT score 0.09 | Open Targets | UniProt Ensembl Open Targets |
| AGTR1
angiotensin II receptor type 1 |
Molecular | Gene | — | — | OT score 0.09 | Open Targets | UniProt Ensembl Open Targets |
| GH1
growth hormone 1 |
Molecular | Gene | — | — | OT score 0.08 | Open Targets | UniProt Ensembl Open Targets |
| FCGRT
Fc gamma receptor and transporter |
Molecular | Gene | — | — | OT score 0.08 | Open Targets | UniProt Ensembl Open Targets |
| ACHE
acetylcholinesterase (Yt blood group) |
Molecular | Gene | — | — | OT score 0.08 | Open Targets | UniProt Ensembl Open Targets |
| CYP3A4
cytochrome P450 family 3 subfamily A member 4 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| CYP3A43
cytochrome P450 family 3 subfamily A member 43 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| CYP3A5
cytochrome P450 family 3 subfamily A member 5 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| CYP3A7
cytochrome P450 family 3 subfamily A member 7 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| GNRHR
gonadotropin releasing hormone receptor |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| OPRD1
opioid receptor delta 1 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| OPRK1
opioid receptor kappa 1 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| OPRM1
opioid receptor mu 1 |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| PGR
progesterone receptor |
Molecular | Gene | — | — | OT score 0.07 | Open Targets | UniProt Ensembl Open Targets |
| CHRNA3
cholinergic receptor nicotinic alpha 3 subunit |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CHRNB4
cholinergic receptor nicotinic beta 4 subunit |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CHGA
chromogranin A |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SLC7A9
solute carrier family 7 member 9 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| COMT
catechol-O-methyltransferase |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CLCN5
Cl-/H+ antiporter 5 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| UMOD
uromodulin |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CA1
carbonic anhydrase 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CA12
carbonic anhydrase 12 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CA2
carbonic anhydrase 2 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| CA4
carbonic anhydrase 4 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN1
glutamate ionotropic receptor NMDA type subunit 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN2C
glutamate ionotropic receptor NMDA type subunit 2C |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN2D
glutamate ionotropic receptor NMDA type subunit 2D |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN3A
glutamate ionotropic receptor NMDA type subunit 3A |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GRIN3B
glutamate ionotropic receptor NMDA type subunit 3B |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GUCY1A2
guanylate cyclase 1 soluble subunit alpha 2 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| GUCY1B1
guanylate cyclase 1 soluble subunit beta 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| PTGS1
prostaglandin-endoperoxide synthase 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| PTGS2
prostaglandin-endoperoxide synthase 2 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SLC6A3
solute carrier family 6 member 3 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SSTR1
somatostatin receptor 1 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SSTR2
somatostatin receptor 2 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SSTR3
somatostatin receptor 3 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SSTR4
somatostatin receptor 4 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| SSTR5
somatostatin receptor 5 |
Molecular | Gene | — | — | OT score 0.06 | Open Targets | UniProt Ensembl Open Targets |
| ACE2
angiotensin converting enzyme 2 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| REN
renin |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| SLC22A12
solute carrier family 22 member 12 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| SLC16A10
solute carrier family 16 member 10 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| AGXT
alanine--glyoxylate aminotransferase |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| STUB1
STIP1 homology and U-box containing protein 1 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| OTC
ornithine transcarbamylase |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| SLC13A2
solute carrier family 13 member 2 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| CLDN2
claudin 2 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| CNP
2',3'-cyclic nucleotide 3' phosphodiesterase |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| SGK1
serum/glucocorticoid regulated kinase 1 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| RET
ret proto-oncogene |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| AQP7
aquaporin 7 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| AQP7B
aquaporin 7B |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | UniProt Ensembl Open Targets |
| AQP7P3
aquaporin 7 pseudogene 3 |
Molecular | Gene | — | — | OT score 0.05 | Open Targets | Ensembl Open Targets |
| HAL
histidine ammonia-lyase |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| SLC26A4
solute carrier family 26 member 4 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| GRHPR
glyoxylate and hydroxypyruvate reductase |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| WHAMM
WASP homolog associated with actin, golgi membranes and microtubules |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| AVP
arginine vasopressin |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| SLC2A9
solute carrier family 2 member 9 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| WNK4
WNK lysine deficient protein kinase 4 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| NOS3
nitric oxide synthase 3 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| SLC3A1
solute carrier family 3 member 1 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| CALCA
calcitonin related polypeptide alpha |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| NOS1
nitric oxide synthase 1 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| CEBPD
CCAAT enhancer binding protein delta |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| MOCS1
molybdenum cofactor synthesis 1 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| NOS2
nitric oxide synthase 2 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| PTGDR2
prostaglandin D2 receptor 2 |
Molecular | Gene | — | — | OT score 0.04 | Open Targets | UniProt Ensembl Open Targets |
| NPPA
natriuretic peptide A |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| ADM
adrenomedullin |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| AR
androgen receptor |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| GSTM1
glutathione S-transferase mu 1 |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| GIP
gastric inhibitory polypeptide |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| POMC
proopiomelanocortin |
Molecular | Gene | — | — | OT score 0.03 | Open Targets | UniProt Ensembl Open Targets |
| EDNRA
endothelin receptor type A |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| DBH
dopamine beta-hydroxylase |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| IL1B
interleukin 1 beta |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| NPPC
natriuretic peptide C |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| RETN
resistin |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| OPRL1
opioid related nociceptin receptor 1 |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| S100A6
S100 calcium binding protein A6 |
Molecular | Gene | — | — | OT score 0.02 | Open Targets | UniProt Ensembl Open Targets |
| MB
myoglobin |
Molecular | Gene | — | — | OT score 0.01 | Open Targets | UniProt Ensembl Open Targets |
| 24 Hour Urinary Catecholamine (DOPA) Excretion During Treatment Normalized to Creatinine | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | LOINC |
| Blood pressure | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Change from baseline in quality of life over time | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Composite Dysautonomia Symptom Score (COMPASS 31) | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| EQ-5D-5L Quality of Life Score | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| End-tidal CO2 levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Fatigue Severity Scale (FSS) | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Heart Rate | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Medical Research Council (MRC) Dyspnoea Scale | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Morning salivary cortisol levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Neuro Quality of Life Score | Trial outcome measure | Clinical scale | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma Catecholamines (Norepinephrine) After the Last Dose of Placebo or Carbidopa | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma Dopamine | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma HS-CRP levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | LOINC |
| Plasma IL-1 levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma IL-10 levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma IL-6 levels | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma Norepinephrine | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Plasma Volume | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Post-Exertional Malaise (PEM) Screener | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Urinary Dopa | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Urinary Dopamine | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Urinary Norepinephrine | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
| Urinary Sodium | Trial outcome measure | Lab value | — | — | Trial outcome measure | ClinicalTrials.gov | — |
Every alteration recorded for this condition is missing a direction or frequency value.
Therapeutics
Direct disease associations, biomarker-linked drugs, OSMF narrative-review natural agents, and merged ranking. Only agents with registry trials or published clinical literature are shown by default.
| Drug | Type | Phase | Evidence | Score | Price (UK / US) | Trials & literature | Sources | Links |
|---|---|---|---|---|---|---|---|---|
| ACETAZOLAMIDE Repurposing | Small molecule | Approved | Strong | 95 | UK £3–£8 / 28–56 tabs · US $8–$15 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| ACETYLCYSTEINE Repurposing | Small molecule | Approved | Strong | 95 | UK £5–£12 / 30 tabs or effervescent · US $8–$15 / 30-60 tabs (NAC) | No indexed hits View evidence |
DGIdb | — |
| ALLOPURINOL Repurposing | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $4–$10 / 30-90 tabs | No indexed hits View evidence |
DGIdb | — |
| AMPHETAMINE Repurposing | Small molecule | Approved | Strong | 95 | UK Controlled — specialist pricing · US Varies (branded higher) | — | ChEMBL | ChEMBL Open Targets |
| ARGIPRESSIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ASPARAGINASE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| ATENOLOL Repurposing | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | DGIdb | — |
| BICALUTAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| BICALUTAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| BOSUTINIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| CAMPTOTHECIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CANNABIDIOL Repurposing | Small molecule | Approved | Strong | 95 | UK Varies (specialist) · US $30–$80 / 30-day (varies by product) | No indexed hits View evidence |
DGIdb | — |
| CARBACHOL Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CARBOPLATIN Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| CARVEDILOL Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | DGIdb | — |
| CETUXIMAB Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| CHORIOGONADOTROPIN ALFA Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CIPROFLOXACIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CIPROFLOXACIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CISPLATIN Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| CLOMIPRAMINE Repurposing | Small molecule | Approved | Strong | 95 | UK £5–£12 / 28 tabs · US $8–$20 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| CURCUMIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| CYCLOPHOSPHAMIDE ANHYDROUS Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| DACARBAZINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DASATINIB ANHYDROUS Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| DAUNORUBICIN LIPOSOMAL Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DIAZEPAM Repurposing | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| DICHLORPHENAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIETHYLSTILBESTROL Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DOCETAXEL ANHYDROUS Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| DOXORUBICIN HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| ENZALUTAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| EPIRUBICIN Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | ChEMBL | ChEMBL Open Targets |
| ERYTHROMYCIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ESTRAMUSTINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ETHOXZOLAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ETOPOSIDE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| FLOXURIDINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| FLUDARABINE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| FLUMAZENIL Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FLUOROURACIL Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| GEMCITABINE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| GLYBURIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| IMIPRAMINE Repurposing | Small molecule | Approved | Strong | 95 | UK Low cost · US Low cost | — | ChEMBL | ChEMBL Open Targets |
| INDAPAMIDE Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£4 / 28 tabs · US $5–$10 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| INDOMETHACIN Repurposing | Small molecule | Approved | Strong | 95 | UK £3–£8 / 28–56 tabs · US $6–$15 / 30–60 tabs | — | ChEMBL | ChEMBL Open Targets |
| INTERFERON ALFA-2B Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| IRINOTECAN HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| ISOSORBIDE DINITRATE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| LEUCOVORIN CALCIUM Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| LEVODOPA Repurposing | Small molecule | Approved | Strong | 95 | UK Varies (often combo) · US Varies | — | DGIdb | — |
| MAFENIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MECAMYLAMINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MEDROXYPROGESTERONE ACETATE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| METHAZOLAMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| METHOTREXATE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| METHOXSALEN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| METOPROLOL Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£4 / 28 tabs · US $4–$9 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| MIANSERIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MITOXANTRONE HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| NALIDIXIC ACID Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| NALTREXONE HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | UK £15–£30 / 28–50 tabs (low-dose) · US $20–$40 / 30 tabs | — | DGIdb | — |
| NEVIRAPINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| NICOTINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| NICOTINE POLACRILEX Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| NIRAPARIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| NORFLOXACIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| OFLOXACIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| OLAPARIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| OXALIPLATIN Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| PEGASPARGASE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| PHENOBARBITAL Repurposing | Small molecule | Approved | Strong | 95 | UK £3–£10 / supply · US $5–$15 / 30 tabs | — | DGIdb | — |
| PHENYLEPHRINE HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | UK Low cost generic · US Very low cost | — | DGIdb | — |
| PHENYTOIN Repurposing | Small molecule | Approved | Strong | 95 | UK £3–£8 / supply · US $6–$15 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| PRASTERONE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| PRAVASTATIN SODIUM Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| PRAZOSIN Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£6 / 28–60 tabs · US $5–$12 / 30–60 tabs | — | ChEMBL | ChEMBL Open Targets |
| PREDNISOLONE Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | DGIdb | — |
| PREDNISONE Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28–30 tabs · US $4–$8 / 30 tabs | No indexed hits View evidence |
DGIdb | — |
| PROCARBAZINE HYDROCHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ROFECOXIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| RUCAPARIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| SACITUZUMAB GOVITECAN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| SILDENAFIL Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£8 / 4–8 tabs (generic) · US $5–$15 / 10-30 tabs | No indexed hits View evidence |
DGIdb | — |
| SIROLIMUS Repurposing | Small molecule | Approved | Strong | 95 | UK Specialty — £100s per pack · US $50–$200+ / supply (varies) | — | DGIdb | — |
| SIROLIMUS Repurposing | Small molecule | Approved | Strong | 95 | UK Specialty — £100s per pack · US $50–$200+ / supply (varies) | — | ChEMBL | ChEMBL Open Targets |
| SODIUM CHLORIDE Repurposing | Small molecule | Approved | Strong | 95 | UK Very low (tablets or solution) · US Very low | — | DGIdb | — |
| SULBACTAM Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TACROLIMUS ANHYDROUS Repurposing | Small molecule | Approved | Strong | 95 | UK Specialty · US $30–$100+ / supply | — | ChEMBL | ChEMBL Open Targets |
| TALAZOPARIB Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| TAZOBACTAM Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TEMOZOLOMIDE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| TESTOSTERONE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| TRETINOIN Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| TROGLITAZONE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| VERAPAMIL Repurposing | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $4–$10 / 30–60 tabs | — | DGIdb | — |
| VINORELBINE Repurposing | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| ZIDOVUDINE Repurposing | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DARAPLADIB Repurposing | Small molecule | Phase III | Moderate | 70 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FENRETINIDE Repurposing | Small molecule | Phase III | Moderate | 70 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| COMPOUND 2 [PMID: 22380603] Repurposing | Small molecule | Phase II | Emerging | 50 | Research / experimental compound — pricing not applicable for routine clinical use | — | DGIdb | — |
| RETINOIC ACID AGENT Repurposing | Small molecule | Phase II | Emerging | 50 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ALPRENOLOL Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| AMIFLOXACIN Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| BROLAMFETAMINE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CARZENIDE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIFLOXACIN Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIMECAMINE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ELLAGIC ACID Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ENISOPROST Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FENCAMFAMIN Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FLEROXACIN Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| IDOXIFENE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| LYSERGIDE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MERAFLOXACIN Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TENAMFETAMINE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ZIDAPAMIDE Repurposing | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| Midodrine Repurposing | Small molecule | Approved | Strong | 90 | UK £55–£75 / 100 tabs (2.5-5mg) · US $18 / 90 tabs (2.5mg, Cost Plus) | — | — | |
| Pyridostigmine Repurposing | Small molecule | Approved | Strong | 90 | UK £15–£25 / 60 tabs · US $20–$35 / 30–60 tabs | — | — | |
| Fludrocortisone Repurposing | Small molecule | Approved | Strong | 90 | UK £6–£10 / 30 tabs (0.1mg) · US $6 / 30 tabs (0.1mg, Cost Plus) | — | — | |
| Sildenafil Repurposing | Small molecule | Active trials | Strong | 90 | UK £2–£8 / 4–8 tabs (generic) · US $5–$15 / 10-30 tabs | — | — | |
| Propranolol Repurposing | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28–56 tabs · US $4–$10 / 30–60 tabs | — | — | |
| Atenolol Repurposing | Small molecule | Approved | Strong | 90 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | — | |
| Carvedilol Repurposing | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | — | |
| Metoprolol Repurposing | Small molecule | Approved | Strong | 90 | UK £2–£4 / 28 tabs · US $4–$9 / 30 tabs | — | — | |
| Verapamil Repurposing | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28 tabs · US $4–$10 / 30–60 tabs | — | — | |
| Ivabradine Repurposing | Small molecule | Approved | Strong | 90 | UK £28–£40 / 56 tabs (5mg) · US $28 / 60 tabs (5mg, Cost Plus) | — | — | |
| Atomoxetine Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £20–£40 / 28 tabs · US $30–$70 / 30 tabs | — | — | |
| Ephedrine Repurposing | Small molecule | Approved | Strong | 90 | UK £5–£15 / supply (hospital/OTC limits) · US $10–$25 / supply | — | — | |
| Apixaban Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £20–£50 / 28-60 tabs · US $30–$70 / 30-60 tabs | — | — | |
| Rivaroxaban Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £20–£50 / 28 tabs (varies by dose) · US $30–$80 / 30 tabs | — | — | |
| Gabapentin Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £2–£5 / 28–100 tabs · US $5–$12 / 30–90 tabs | — | — | |
| Amitriptyline Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £1–£3 / 28 tabs · US $4–$10 / 30 tabs | — | — | |
| Sertraline Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £1–£3 / 28 tabs · US $4–$9 / 30 tabs | — | — | |
| Paroxetine Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £2–£4 / 28 tabs · US $5–$10 / 30 tabs | — | — | |
| IVIG Repurposing | Small molecule | Clinical trials | Strong | 90 | Research / experimental compound — pricing not applicable for routine clinical use | — | — | |
| Methylphenidate Repurposing | Small molecule | Clinical trials | Strong | 90 | UK £10–£25 / 28–30 tabs (generic) · US $15–$40 / 30 tabs | — | — |
No therapeutics in this section.
| Drug | Type | Phase | Evidence | Score | Price (UK / US) | Trials & literature | Sources | Links |
|---|---|---|---|---|---|---|---|---|
| ACETAZOLAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £3–£8 / 28–56 tabs · US $8–$15 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| ACETYLCYSTEINE Repurposing via ACO1 | Small molecule | Approved | Strong | 95 | UK £5–£12 / 30 tabs or effervescent · US $8–$15 / 30-60 tabs (NAC) | No indexed hits View evidence |
DGIdb | — |
| ALLOPURINOL Repurposing via CCHCR1 | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $4–$10 / 30-90 tabs | No indexed hits View evidence |
DGIdb | — |
| AMPHETAMINE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK Controlled — specialist pricing · US Varies (branded higher) | — | ChEMBL | ChEMBL Open Targets |
| ARGIPRESSIN Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ASPARAGINASE Repurposing via CCHCR1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| ATENOLOL Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | DGIdb | — |
| BICALUTAMIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| BICALUTAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| BOSUTINIB Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| CAMPTOTHECIN Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CANNABIDIOL Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | UK Varies (specialist) · US $30–$80 / 30-day (varies by product) | No indexed hits View evidence |
DGIdb | — |
| CARBACHOL Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CARBOPLATIN Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| CARVEDILOL Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | DGIdb | — |
| CETUXIMAB Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| CHORIOGONADOTROPIN ALFA Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CIPROFLOXACIN Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| CIPROFLOXACIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CISPLATIN Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| CLOMIPRAMINE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £5–£12 / 28 tabs · US $8–$20 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| CURCUMIN Repurposing via CAMK2A | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| CYCLOPHOSPHAMIDE ANHYDROUS Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| DACARBAZINE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DASATINIB ANHYDROUS Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| DAUNORUBICIN LIPOSOMAL Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DIAZEPAM Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| DICHLORPHENAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIETHYLSTILBESTROL Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DOCETAXEL ANHYDROUS Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| DOXORUBICIN HYDROCHLORIDE Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| ENZALUTAMIDE Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| EPIRUBICIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | ChEMBL | ChEMBL Open Targets |
| ERYTHROMYCIN Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ESTRAMUSTINE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ETHOXZOLAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ETOPOSIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| FLOXURIDINE Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| FLUDARABINE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| FLUMAZENIL Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FLUOROURACIL Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| GEMCITABINE Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| GLYBURIDE Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| IMIPRAMINE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK Low cost · US Low cost | — | ChEMBL | ChEMBL Open Targets |
| INDAPAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £2–£4 / 28 tabs · US $5–$10 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| INDOMETHACIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £3–£8 / 28–56 tabs · US $6–$15 / 30–60 tabs | — | ChEMBL | ChEMBL Open Targets |
| INTERFERON ALFA-2B Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| IRINOTECAN HYDROCHLORIDE Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | No indexed hits View evidence |
DGIdb | — |
| ISOSORBIDE DINITRATE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| LEUCOVORIN CALCIUM Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| LEVODOPA Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK Varies (often combo) · US Varies | — | DGIdb | — |
| MAFENIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MECAMYLAMINE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MEDROXYPROGESTERONE ACETATE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| METHAZOLAMIDE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| METHOTREXATE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| METHOXSALEN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| METOPROLOL Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £2–£4 / 28 tabs · US $4–$9 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| MIANSERIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MITOXANTRONE HYDROCHLORIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| NALIDIXIC ACID Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| NALTREXONE HYDROCHLORIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £15–£30 / 28–50 tabs (low-dose) · US $20–$40 / 30 tabs | — | DGIdb | — |
| NEVIRAPINE Repurposing via CCHCR1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| NICOTINE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| NICOTINE POLACRILEX Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| NIRAPARIB Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| NORFLOXACIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| OFLOXACIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| OLAPARIB Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| OXALIPLATIN Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| PEGASPARGASE Repurposing via CCHCR1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| PHENOBARBITAL Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £3–£10 / supply · US $5–$15 / 30 tabs | — | DGIdb | — |
| PHENYLEPHRINE HYDROCHLORIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK Low cost generic · US Very low cost | — | DGIdb | — |
| PHENYTOIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £3–£8 / supply · US $6–$15 / 30 tabs | — | ChEMBL | ChEMBL Open Targets |
| PRASTERONE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| PRAVASTATIN SODIUM Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| PRAZOSIN Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK £2–£6 / 28–60 tabs · US $5–$12 / 30–60 tabs | — | ChEMBL | ChEMBL Open Targets |
| PREDNISOLONE Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | DGIdb | — |
| PREDNISONE Repurposing via CCHCR1 | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28–30 tabs · US $4–$8 / 30 tabs | No indexed hits View evidence |
DGIdb | — |
| PROCARBAZINE HYDROCHLORIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ROFECOXIB Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| RUCAPARIB Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| SACITUZUMAB GOVITECAN Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| SILDENAFIL Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | UK £2–£8 / 4–8 tabs (generic) · US $5–$15 / 10-30 tabs | No indexed hits View evidence |
DGIdb | — |
| SIROLIMUS Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK Specialty — £100s per pack · US $50–$200+ / supply (varies) | — | DGIdb | — |
| SIROLIMUS Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK Specialty — £100s per pack · US $50–$200+ / supply (varies) | — | ChEMBL | ChEMBL Open Targets |
| SODIUM CHLORIDE Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK Very low (tablets or solution) · US Very low | — | DGIdb | — |
| SULBACTAM Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TACROLIMUS ANHYDROUS Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | UK Specialty · US $30–$100+ / supply | — | ChEMBL | ChEMBL Open Targets |
| TALAZOPARIB Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| TAZOBACTAM Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TEMOZOLOMIDE Repurposing via BRCA2 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | No indexed hits View evidence |
DGIdb | — |
| TESTOSTERONE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| TRETINOIN Repurposing via BAX | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| TROGLITAZONE Repurposing via AARS1 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| VERAPAMIL Repurposing via BAX | Small molecule | Approved | Strong | 95 | UK £2–£5 / 28 tabs · US $4–$10 / 30–60 tabs | — | DGIdb | — |
| VINORELBINE Repurposing via BAX | Small molecule | Approved | Strong | 95 | Hospital / IV specialty — prices per vial or dose (often hundreds–thousands USD/GBP) | — | DGIdb | — |
| ZIDOVUDINE Repurposing via ABCC5 | Small molecule | Approved | Strong | 95 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| DARAPLADIB Repurposing via AARS1 | Small molecule | Phase III | Moderate | 70 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FENRETINIDE Repurposing via AARS1 | Small molecule | Phase III | Moderate | 70 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| COMPOUND 2 [PMID: 22380603] Repurposing via ABCC5 | Small molecule | Phase II | Emerging | 50 | Research / experimental compound — pricing not applicable for routine clinical use | — | DGIdb | — |
| RETINOIC ACID AGENT Repurposing via APOD | Small molecule | Phase II | Emerging | 50 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | DGIdb | — |
| ALPRENOLOL Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| AMIFLOXACIN Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| BROLAMFETAMINE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| CARZENIDE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIFLOXACIN Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| DIMECAMINE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ELLAGIC ACID Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ENISOPROST Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FENCAMFAMIN Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| FLEROXACIN Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| IDOXIFENE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| LYSERGIDE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| MERAFLOXACIN Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| TENAMFETAMINE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| ZIDAPAMIDE Repurposing via AARS1 | Small molecule | Phase II | Emerging | 45 | Varies — check openprescribing.net (UK) or costplusdrugs.com / GoodRx (US) | — | ChEMBL | ChEMBL Open Targets |
| Midodrine Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £55–£75 / 100 tabs (2.5-5mg) · US $18 / 90 tabs (2.5mg, Cost Plus) | — | — | |
| Pyridostigmine Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £15–£25 / 60 tabs · US $20–$35 / 30–60 tabs | — | — | |
| Fludrocortisone Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £6–£10 / 30 tabs (0.1mg) · US $6 / 30 tabs (0.1mg, Cost Plus) | — | — | |
| Sildenafil Repurposing via Clinical Trial | Small molecule | Active trials | Strong | 90 | UK £2–£8 / 4–8 tabs (generic) · US $5–$15 / 10-30 tabs | — | — | |
| Propranolol Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28–56 tabs · US $4–$10 / 30–60 tabs | — | — | |
| Atenolol Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £1–£3 / 28 tabs · US $3–$8 / 30 tabs | — | — | |
| Carvedilol Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28 tabs · US $5–$10 / 30 tabs | — | — | |
| Metoprolol Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £2–£4 / 28 tabs · US $4–$9 / 30 tabs | — | — | |
| Verapamil Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £2–£5 / 28 tabs · US $4–$10 / 30–60 tabs | — | — | |
| Ivabradine Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £28–£40 / 56 tabs (5mg) · US $28 / 60 tabs (5mg, Cost Plus) | — | — | |
| Atomoxetine Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £20–£40 / 28 tabs · US $30–$70 / 30 tabs | — | — | |
| Ephedrine Repurposing via Clinical Trial | Small molecule | Approved | Strong | 90 | UK £5–£15 / supply (hospital/OTC limits) · US $10–$25 / supply | — | — | |
| Apixaban Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £20–£50 / 28-60 tabs · US $30–$70 / 30-60 tabs | — | — | |
| Rivaroxaban Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £20–£50 / 28 tabs (varies by dose) · US $30–$80 / 30 tabs | — | — | |
| Gabapentin Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £2–£5 / 28–100 tabs · US $5–$12 / 30–90 tabs | — | — | |
| Amitriptyline Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £1–£3 / 28 tabs · US $4–$10 / 30 tabs | — | — | |
| Sertraline Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £1–£3 / 28 tabs · US $4–$9 / 30 tabs | — | — | |
| Paroxetine Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £2–£4 / 28 tabs · US $5–$10 / 30 tabs | — | — | |
| IVIG Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | Research / experimental compound — pricing not applicable for routine clinical use | — | — | |
| Methylphenidate Repurposing via Clinical Trial | Small molecule | Clinical trials | Strong | 90 | UK £10–£25 / 28–30 tabs (generic) · US $15–$40 / 30 tabs | — | — |
Alterations and therapeutics are aggregated from public databases (Open Targets, HPO, ChEMBL, DGIdb, and others). Natural agents are candidates from OSMF narrative reviews on opensourcemed.info/chronic-disease.html — not approved treatments. This page is for research orientation only — not medical advice.
Generated by OSMF Disease Intelligence Pipeline · Schema 1.1.0